Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Morales

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Clinical Drug Investigation|May 16, 2019
Addendum to: Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control StudyDaniel R Morales, Rob Flynn, Xavier Kurz
Trials|February 28, 2020
Exclusion rates in randomized controlled trials of treatments for physical conditions: a systematic reviewJinzhang He, Daniel R Morales, Bruce Guthrie
Nature|December 22, 2021
Early-career researchers help Wellcome funding panelRachel V Guest, Laura Benjamin, Daniel R Morales
BMC Medicine|January 16, 2018
Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerationsDaniel R Morales, Jim Slattery, Stephen Evans, et al.
British Journal of Clinical Pharmacology|March 30, 2021
Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerationsDaniel R Morales, Lionel Fonkwen, Hedvig M E Nordeng
British Journal of Clinical Pharmacology|February 19, 2020
Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: A series of population-based nested case-control studiesDaniel R Morales, Alexandra Pacurariu, Jim Slattery, et al.
British Journal of Clinical Pharmacology|November 7, 2017
Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerationsThomas Goedecke, Daniel R Morales, Alexandra Pacurariu, et al.
Thorax|September 4, 2012
Long-acting β-agonist prescribing in people with asthma in primary careDaniel R Morales, Cathy Jackson, Shona Fielding, et al.
Kidney International|April 16, 2015
Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injuryTobias Dreischulte, Daniel R Morales, Samira Bell, et al.
British Journal of Clinical Pharmacology|July 5, 2018
Response to 'Comment on 'Measuring the impact of medicines regulatory interventions - systematic review and methodological considerations' by Goedecke et al.'Thomas Goedecke, Daniel R Morales, Alexandra Pacurariu, et al.
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Clinical Drug Investigation|May 16, 2019
Addendum to: Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control StudyDaniel R Morales, Rob Flynn, Xavier Kurz
Trials|February 28, 2020
Exclusion rates in randomized controlled trials of treatments for physical conditions: a systematic reviewJinzhang He, Daniel R Morales, Bruce Guthrie
Nature|December 22, 2021
Early-career researchers help Wellcome funding panelRachel V Guest, Laura Benjamin, Daniel R Morales
BMC Medicine|January 16, 2018
Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerationsDaniel R Morales, Jim Slattery, Stephen Evans, et al.
British Journal of Clinical Pharmacology|March 30, 2021
Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerationsDaniel R Morales, Lionel Fonkwen, Hedvig M E Nordeng
British Journal of Clinical Pharmacology|February 19, 2020
Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: A series of population-based nested case-control studiesDaniel R Morales, Alexandra Pacurariu, Jim Slattery, et al.
British Journal of Clinical Pharmacology|November 7, 2017
Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerationsThomas Goedecke, Daniel R Morales, Alexandra Pacurariu, et al.
Thorax|September 4, 2012
Long-acting β-agonist prescribing in people with asthma in primary careDaniel R Morales, Cathy Jackson, Shona Fielding, et al.
Kidney International|April 16, 2015
Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injuryTobias Dreischulte, Daniel R Morales, Samira Bell, et al.
British Journal of Clinical Pharmacology|July 5, 2018
Response to 'Comment on 'Measuring the impact of medicines regulatory interventions - systematic review and methodological considerations' by Goedecke et al.'Thomas Goedecke, Daniel R Morales, Alexandra Pacurariu, et al.
Pageof 12